| Typicality: | 0.363 |
| Saliency: | 0.264 |
| during opioid dependence treatment | 3 | temporal |
| in the us | 2 | location |
| methadone → be approved for → use | 5 |
| methadone → be approved by → the fda | 3 |
| negative | neutral | positive |
| 0.078 | 0.475 | 0.447 |
| Raw frequency | 8 |
| Normalized frequency | 0.264 |
| Modifier score | 0.500 |
| Perplexity | 58.829 |